Меню
Идёт набор NCT05363059

Effect of Bariatric Surgery Versus Medical Therapy on Metabolic Syndrome

Наблюдательное Metabolic Syndrome

Ориентир для пациента и семьи

Простыми словами

Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.

Что изучают
В протоколе указаны: Hypoglycemic drugs, Bariatric surgery.
Кому может быть актуально
Состояния в реестре: Metabolic Syndrome. Базовые параметры: 18 лет — 65 лет · Все.
Что важно проверить
Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
Где проводится
Китай
Следующий шаг
Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Официальное название

Army Medical University

Обзор

Bariatric surgery (BS) is known to improve the components of metabolic syndrome (MS) in obese patients. However, few studies have evaluated the impact of bariatric surgery versus medical therapy (MT) in patients with MS, especially in patients with low body mass index (BMI). This study aimed to assess the effect of bariatric surgery on MS in patients with low BMI by comparing BS (BMI\<35 kg/m2 and BMI≥35 kg/m2) with MT (BMI\<35 kg/m2). A retrospective study including patients with MS undergoing bariatric surgery and medical therapy at a single institution. We follow up the 5 years effect of bariatric surgery versus medical therapy on the remission of MS, its individual components, atherosclerotic cardiovascular disease (ASCVD) risk, and medication used.

Подробное описание

1. Study design and patients

This study aimed to compare bariatric surgery(BS) with medical therapy (MT) for the management of low BMI patients with MS, approved by the ethics committee and institutional review at our hospital. 100 patients underwent bariatric surgery and 100 patients receiving medical therapy for obesity and type 2 diabetes between 2010 and 2020 at our institution. All patients met the Chinese guidelines developed by the Chinese Society for Metabolic \& Bariatric surgery (CSMBS). All patients achieve diagnostic criteria for MS, defined by the presence of at least 3 of the 5 following criteria derived from the joint interim statement (JIS) definition. 2. outcome and Data collection

All patients follow up the change of improvement in MS and its components following bariatric surgery and medical therapy, including waist circumference, hyperglycemia, hypertension, hyperlipidemia, long-term CVD risk, and medication use 3. Treatments

3.1 BS group The bariatric surgical procedures performed included Roux-en-Y gastric bypass and sleeve gastrectomy.

3.2 MT group According to the guidelines in China, patients in the medical therapy group received glucose-lowering, lipid-lowering, and antihypertensive medications, with the following targets: glycosylated hemoglobin\<7%; systolic blood pressure\<140 mmHg, diastolic blood pressure\<80 mmHg; low-density lipoprotein cholesterol\<2.6 mmol/L; and high-density lipoprotein cholesterol\>1.3 mmol/L for female or 1.0 mmol/L for male.

Вмешательства

  • Препарат Hypoglycemic drugs
    drug
  • Процедура Bariatric surgery
    surgery

Первичные конечные точки

  • Change in metabolic parameters from baseline to 5 years. [Срок оценки: baseline to 5 years]
  • Change in metabolic parameters from baseline to 5 years. [Срок оценки: baseline to 5 years]
Вторичные конечные точки (7)
  • Change in glycosylated hemoglobin from baseline to 5 years. [Срок оценки: baseline to 5 years]
  • Change in plasma glucose from baseline to 5 years. [Срок оценки: baseline to 5 years]
  • Change in blood lipids from baseline to 5 years. [Срок оценки: baseline to 5 years]
  • Changes of CVD risk [Срок оценки: baseline to 5 years]
  • Hypoglycemic drugs use [Срок оценки: baseline to 5 years]
  • Antihypertensive drugs use [Срок оценки: baseline to 5 years]
  • Lipid-lowering drugs use [Срок оценки: baseline to 5 years]

Критерии участия

  • Inclusion Criteria:
  • BMI<35 kg/m\^2
  • Underwent bariatric surgery or medical therapy
  • Patients met the diagnostic criteria for MS, defined criteria derived from the joint interim statement (JIS)
  • Exclusion Criteria:
  • Patients who failed to follow up
  • Insulin dependent diabetes
  • congenital dementia
  • brain trauma
  • epileps
  • severe hypoglycemic coma
  • cerebrovascular disease
  • ischemic
  • heart disease
  • renal dysfunction
  • alcohol abuse
  • mental illness
  • psychoactive substance abuse
  • unwillingness to provide informed consent

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Модель наблюдения
Когортное

Центры проведения

Китай · 1 центр
  • Stryker Laparoscopy — Чунцин

Идентификаторы

NCT: NCT05363059 · EBSMTMS

Первоисточники (государственные реестры)

Открыть это исследование на ClinicalTrials.gov ↗